More than 40 of the world’s leading experts on the effective use of prolotherapy to treat musculoskeletal and joint pain will gather for the 20th annual Prolotherapy Research Symposium and Conference, set for October 21-24, 2015, at the University of Wisconsin-Madison.
Hundreds of physicians from across the globe will attend the four-day event for the latest studies and research findings on the efficacy of prolotherapy, a form of regenerative injection therapy. They will also get hands-on training in proper utilization of prolotherapy, which is the treatment of tissue with the injection of an irritant solution such as dextrose into a joint space, weakened ligament, or tendon to relieve pain.
This year’s conference is titled: “The Anatomy, Diagnosis and Treatment of Myofascial Pain with Prolotherapy.” Myofascial pain is a chronic condition that affects the fascia, the connective tissue covering the muscles.
Conference-goers will learn about the basic and advanced use of prolotherapy to treat laxity of ligaments (loose ligaments) that often cause myofascial pain. The conference will include hands-on workshops and presentations on new clinical science research in injection therapy for conditions such as knee osetoarthritis, low pack pain and tendinopathies.
The Prolotherapy Symposium and Conference are organized by the University of Wisconsin School of Public Health; the Department of Family Medicine and Community Health; the Office of Continuing Professional Development in Medicine and Public Health; and the non-profit Hackett Hemwall Patterson Foundation. A major focus of the HHPF is to train physicians from across the globe in the latest in prolotherapy techniques.
For more information about the prolotherapy conference, visit www.hacketthemwall.org/Madison_Conf.html.